Retrospective Observational Evaluation of the Bone Mineral Density Outcome in Young Women With Amenorrhea

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Jun 3, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how different treatments with estrogen can affect bone health in young women who have amenorrhea, which means they haven’t had their period for more than six months. The researchers want to see which treatment helps improve bone density, a measure of bone strength, by comparing bone scans done before starting treatment and again after at least a year. They will check important areas like the spine and hip to get a complete picture of bone health. Additionally, they will explore how these treatments might affect other health aspects in the body.

To be eligible for this study, women aged between 15 and 39 who have experienced amenorrhea for at least six months can participate. They should have visited a specific clinic between 2011 and 2020 and must be able to provide informed consent. There are no specific exclusions mentioned, which means more women may have the chance to take part. If you join the study, you can expect to undergo some tests to measure your bone health at the start and after a year of treatment, helping researchers understand the best ways to support women with this condition.

Gender

FEMALE

Eligibility criteria

• Inclusion criteria:
• • Patients who have presented themselves to the O.U. of Gynecology and Human Reproduction Pathophysiology in the period from 2011 to 2020 with amenorrhea over 6 months, and aged between 15 and 39 years at the time of the visit.
• • Patients who have reached the age of 18 at the time of surgery.
• • Patients for whom informed consent has been obtained.
• • Exclusion criteria: No exclusion criteria are provided.